Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Health Reference Charts
Type 1 Issues Archives
Print | Email | Share | Comments (1)

Mice Cured of Type 1 Diabetes: But Will It Work in Humans?


Nov 22, 2007

A study out of Beth Israel Deaconess Medical Center has found that to restore normal glucose levels in type 1 diabetic mice, it's not enough to halt the destruction of their beta cells. You also have to reverse the muscle and fat inflammation that prevents insulin from transferring glucose into those tissues.

The researchers started by giving diabetic mice a combination of three drugs that not only halted the immune destruction of their beta cells, but also relieved the inflammation in their muscle and fat tissues. They found that increasing insulin-producing beta cells and circulating insulin levels weren't enough to achieve good blood sugars.

Instead, the restoration of good blood sugars was linked to relief from the inflammatory state that impaired the mice's response to insulin. Both restoration of beta cells and relief from the inflammatory state in insulin-sensitive tissues were necessary to achieve permanent restoration of normal sugar levels.

Thus, this new triple-therapy regimen, possessing both tolerance-inducing and select anti-inflammatory properties, may represent a way to restore normal blood sugars and self-tolerance in type 1 diabetes. (The three drugs, in case you'd like to know, were rapamycin plus agonist IL-2-related and antagonist-type, mutant IL-15-related Ig fusion proteins (IL-2.Ig and mutIL-15.Ig.))

Sources: EurekAlert; Proceedings of the National Academy of Sciences, August 2007


Categories: Blood Sugar, Diabetes, Diabetes, Insulin, Professional Issues, Type 1 Issues



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 1 comment - Nov 22, 2007

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.